Concepedia

Author

José Luis Ramírez

Institut Català d'OncologiaORCID

Also Known As

C. Plumptre, J DE SAGARMINAGA, J L Ramirez, J L Serrano, J Ramirez, J Ramírez, J Serrano, J. L. Ramirez, J. L. Ramírez, J. L. Ramírez

172

Publications

8.4K

Citations

27

H-Index

75

Concepts

All Affiliations

Institut Català d'OncologiaHospital Universitari Germans Trias i PujolInstitut d'Investigació en Ciències de la Salut Germans Trias i PujolUniversitat Autònoma de BarcelonaHospital General Universitario De Valencia
JL

About

José Luis Ramírez is an author at Institut Català d'Oncologia specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

19

27

6.9K

2

Natural Sciences

3

3

101

3

Biochemistry

2

2

55

4

Biology

2

2

196

5

Health Sciences

1

1

16

José Luis Ramírez

×

49

Publications

8K

Citations

24

H-Index

YearCitations

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Rafael Rosell, Enric Carcereny, Radj Gervais,

The Lancet Oncology

2012

5.5K

The Hippo effector YAP promotes resistance to RAF- and MEK-targeted cancer therapies

Luping Lin, Amit J. Sabnis, Elton Chan,

Nature Genetics

2015

548

Co-activation of STAT3 and YES-Associated Protein 1 (YAP1) Pathway in EGFR-Mutant NSCLC

Imane Chaib, Niki Karachaliou, Sara Pilotto,

JNCI Journal of the National Cancer Institute

2017

216

Molecular karyotype of clone CL Brener chosen for the Trypanosoma cruzi Genome Project

Maria Isabel Nogueira Cano, Arthur Gruber, Martı́n Vázquez,

Molecular and Biochemical Parasitology

1995

150

O6-methyl-guanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1,3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme.

Carmen Balañá, José Luis Ramírez, Miquel Tarón,

PubMed

2003

147

14-3-3σ Methylation in Pretreatment Serum Circulating DNA of Cisplatin-Plus-Gemcitabine-Treated Advanced Non–Small-Cell Lung Cancer Patients Predicts Survival: The Spanish Lung Cancer Group

José Luis Ramírez, Rafael Rosell, Miquel Tarón,

Journal of Clinical Oncology

2005

120

Methylation patterns and K-ras mutations in tumor and paired serum of resected non-small-cell lung cancer patients

José Luis Ramírez, Carme Sarries, Pedro López de Castro,

Cancer Letters

2003

117

Diffuse Alveolar Hemorrhage in Allogeneic Bone Marrow Transplantation: A Postmortem Study

José Luis Ramírez, César Picado, Antoni Xaubet,

American Journal of Respiratory and Critical Care Medicine

1995

108

Genome-Wide Association Study of Survival in Non–Small Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy

Xifeng Wu, Yuanqing Ye, Rafael Rosell,

JNCI Journal of the National Cancer Institute

2011

93

BIM and mTOR expression levels predict outcome to erlotinib in EGFR-mutant non-small-cell lung cancer

Niki Karachaliou, Jordi Codony‐Servat, Cristina Teixidó,

Scientific Reports

2015

64

Page 1